Current concepts of the management of dental extractions for patients taking warfarin

Australian Dental Journal

Volumn 48, Issue 2, 2003, Pages 89-96

  Carter, G ^a   Goss, A N ^a,b   Lloyd, J ^b   Tocchetti, R ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Anticoagulation; Extractions; Oral surgery; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIVITAMIN K; CARBAMAZEPINE; CODEINE; ERYTHROMYCIN; FIBRIN GLUE; HEPARIN; LOCAL ANESTHETIC AGENT; METRONIDAZOLE; MICONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRANEXAMIC ACID; TRIMETHOPRIM; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING; BLOOD VESSEL WALL; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; DEEP VEIN THROMBOSIS; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG MONITORING; DRUG WITHDRAWAL; ECCHYMOSIS; EMBOLISM; FACE EDEMA; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HEART VALVE PROSTHESIS; HEMATOMA; HEMATURIA; HEMOSTASIS; HUMAN; LUNG EMBOLISM; MOUTH CAVITY; MOUTHWASH; PATIENT CARE; PATIENT MONITORING; PROTHROMBIN TIME; RETROPERITONEAL HEMORRHAGE; REVIEW; SIDE EFFECT; SKIN BRUISING; THROMBOCYTE; THROMBOEMBOLISM; TOOTH EXTRACTION; VENOUS THROMBOEMBOLISM;

EID: 0346886945     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2003.tb00015.x     Document Type: Review

References (74)

1. Ziffer AM, Scopp IW, Beck J, Baum J, Berger AR. Profound bleeding after dental extractions during dicumarol therapy. N Engl J Med 1957;256:351-353.
2. Waldrep AC, McKelvey LE. Oral surgery for patients on anticoagulant therapy. J Oral Surg 1968;26:374-380.
3. Johnson RL. Blood loss in oral surgery. J Dent Res 1956:175-184.
4. Greenberg MS, Miller MF, Lynch MA. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants. J Am Dent Assoc 1972;84:583-587.
5. Scoop JW, Fredrics H. Dental extractions in patients undergoing anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1958;11:470-474.
6. Sindet-Pedersen S, Ramstrom G, Bernvil S, Blomback M. Haemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989;320:840-843.
7. Behrmann SJ, Wright IS. Dental surgery during continuous anticoagulant therapy. J Am Dent Assoc 1961;62:172-180.
8. Declerk D, Vinckier F, Vermylen J. Influence of anticoagulation on blood loss following dental extractions. J Dent Res 1992;71:387-390.
9. Akbarian M, Austen WG, Yurchak PM, Scannell JG. Thromboembolic complications of prosthetic cardiac valves. Circulation 1968;37:826-831.
10. Lytle BW, Cosgrove DM, Goormastie M, Loop FD. Aortic valve replacement and coronary bypass grafting for patients with aortic stenosis and coronary artery disease: early and late results. Eur Heart J 1988;Suppl E:143-147.
11. Marshall V. Rebound phenomena after anticoagulant therapy in cerebrovascular disease. Circulation 1963;28:329.
12. Gallus AS. Indications for anticoagulation. Drugs 1983;26:543-549.
13. Michaels L. Incidence of thromboembolism after stopping anticoagulant therapy. Relationship to haemorrhage at the time of termination. JAMA 1971;215:595-599.
14. Duvoison GE, Brandenburg RO, McGoon DC. Factors affecting thromboembolism associated with prosthetic heart valves. Circulation 1967;35(Supp 1):70-76.
15. Wahl MJ. Dental Surgery in anticoagulated patients. Arch Intern Med 1998;158:1610-1616.
16. Gonias SL, Pizzo SV. The biochemistry of haemostasis. Clin Lab Haematol 1986;8:281-306.
17. Walsh PN. Platelet-mediated coagulant protein interactions in haemostasis. Semin Hematol 1985;22:178-186.
18. Miale JB. Laboratory Medicine Haematology. 6th edn. St Louis: Mosby, 1982:772-859.
19. Bjorlen G, Nilsson IM. Fibrinolytic activity in alveoli after tooth extraction. Odontol Rev 1968;19:197-204.
20. Wedgewood D. The fibrinolytic system with special reference to its relevance to oral surgery. Br J Oral Surg 1970;8:82-92.
21. Hidaka N, Maeda K, Kawakoni C, Aono M, Okada H. Fibrinolytic activity of periodontal disease. J Periodontol 1981;52:181-186.
22. Albrechtsen OK, Thaysen JH. Fibrinolytic activity in human saliva. Acta Physiol Scand 1955;35:138-145.
23. Birn H, Fejerskov O. Fibrinolytic activity of human oral epithelial cells. A preliminary report. Scand J Dent Res 1971;79:381-386.
24. Moody GH. Plasminogen in human saliva. Int J Oral Surg 1982;11:110-114.
25. Moody GH. The source of plasminogen activator in human saliva. Arch Oral Biol 1982;27:33-37.
26. Sindet-Pedersen S, Gram J, Jespersen J. The possible role of oral epithelial cells in tissue-type plasminogen activator related fibrinolysis in human saliva. J Dent Res 1990;69:1283-1286.
27. Rijken DC, Wijngards G, Welbergen J. Immunological characterization of plasminogen activator activities in human tissues and body fluids. J Lab Clin Med 1981;97:477-486.
28. Sindet-Pedersen S, Gram J, Jespersen J. Characterization of plasminogen activators in unstimulated and stimulated human whole saliva. J Dent Res 1987;66:1199-1203.
29. Gersel-Pedersen N. Fibrinolytic activity of blood and saliva before and after oral surgery. Int J Oral Surg 1981;10 (Suppl 1):114-121.
30. Clagett GP, Salzmann EW. Prevention of venous thromboembolism. Prog Cardiovasc Dis 1975;17:345-366.
31. Hull RD, Raskob G, Hirsh J. Prophylaxis of venous thromboembolism. An overview. Chest 1986;89:(5 Suppl)374S-383S.
32. Mitchell JRA. Anticoagulant in coronary heart disease: Retospect and prospect. Lancet 1981;198:257-262.
33. Quick AJ. The prothrombin time in haemophilia and in obstructive jaundice. J Biol Chem 1935;109:73-74.
34. Hirsh J, Levine M. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Thromb Haemost 1988;59:129-132.
35. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1992;102(4 suppl):312S-326S.
36. Askey JM, Cherry CB. Dental extraction during dicumarol therapy. Calif Med 1956;84:16-17.
37. Shira RB, Hall RJ, Guernsey LH. Minor oral surgery during prolonged anticoagulant therapy. J Oral Surg 1962;20:93-99.
38. Frank BW, Dickhaus DW, Claus EC. Dental extractions in the presence of continual anticoagulant therapy. Ann Intern Med 1963;59:911-913.
39. Kwapsis B. Anticoagulant therapy and dental practice. J Am Dent Assoc 1963;66:172-175.
40. Bailey BM, Fordyce AM. Complications of dental extractions in patients receiving warfarin anticoagulant therapy. A controlled clinical trial. Br Dent J 1983;155:308-310.
41. Campbell JH, Alvarado F, Murray RA. Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered? J Oral Maxillofac Surg 2000;58:131-135.
42. Devani P, Lavery KM, Howell CJT. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 1998;36:107-111.
43. Blinder D, Manor Y, Martinowitz U, Taicher S. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local haemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:137-140.
44. Malamed SF. Handbook of local anaesthesia. 2nd edn. St Louis: Mosby, 1986:68-82.
45. Duperon DF, Dobbs TM. Dental Care for patients with congenital haemorrhagic disorders. J Can Dent Assoc 1976;42:269-273.
46. Nazif MM. Pain Control in Patients with Haemophilia. In: Powell D, ed. Recent advances in dental care for the haemophiliac. Los Angeles Haemophilia Foundation of Southern California, 1979;58-59.
47. Heine RD. Alternative methods in inferior alveolar anaesthesia. Compend Contin Educ Dent 1985;6:441-448.
48. Borea G, Montebugnoli L, Capuzzi P, Magelli C. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1993;75:29-31.
49. Ramstrom G, Sindet-Pedersen S, Hall G, Blomback M, Alander U. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 1993;51:1211-1216.
50. Souto JC, Oliver A, Zuazu-Jausoro I, Vives A, Fontcuberta J. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 1996;54:27-32.
51. Carter GD, Goss AN. Tranexamic acid mouthwash - A prospective randomized study of a 2-day regimen vs. 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg (in press).
52. Okamoto S, Okamoto U. Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of the fibrinolysis. Keio J Med 1962;11:105-115.
53. Bjoerlin G, Nilsson IM. The effect of antifibrinolytic agents on wound healing. Int J Oral Maxillofac Surg 1988;17:273-276.
54. Vinkier F, Vermylen J. Wound healing following dental extractions in rabbits: Effects of tranexamic acid, warfarin anticoagulation, and socket packing. J Dent Res 1984;63:646-649.
55. Martinowitz U, Mazar AL, Taicher S, et al. Dental extraction for patients on oral anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1990;70:274-277.
56. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U. Dental extractions in patients with bleeding disorders: The use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993;75:280-282.
57. Wepner F, Fries R, Platz H. The use of the fibrin adhesion system for local haemostasis in oral surgery. J Oral Maxillofac Surg 1982;40:555-558.
58. Zusman S, Lustig J, Baston I. Postextraction haemostasis in patients on anticoagulant therapy: the use of a fibrin sealant. Quintessence Int 1992;23:713-716.
59. Davis B, Sandor G. Use of fibrin glue in maxillofacial surgery. J Otolaryngol 1998;27:107-112.
60. Matras H. Fibrin Seal: The state of the art. J Oral Maxillofac Surg 1985;43:605-611.
61. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Eng J Med 1995;332:1661-1665.
62. Carter GD, Goss AN, Lloyd J, Tocchetti R. The comparative effectiveness of a tranexamic acid mouthwash and autologous fibrin glue in patients taking warfarin who require dental extractions - A randomized prospective clinical study. J Oral Maxillofac Surg (in press).
63. Carter G, Goss AN, Lloyd J, Tocchetti. Local haemostasis with autologous fibrin glue following surgical enucleation of a large cystic lesion in a therapeutically anticoagulated patient: a case report. Br J Oral Maxillofac Surg (in press).
64. Mulligan R. Response to anticoagulant drug withdrawal. J Am Dent Assoc 1987;115:435-438.
65. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Eng J Med 1997;336:1506-1511.
66. Davis FB, Sczupak CA. Outpatient oral anticoagulation: guidelines for long-term management. Post Grad Med 1979;66:100-109.
67. Kovacs B, Toth K, Kerenji G. Post-extraction haemostasis during coumarin anticoagulant therapy with a locally applied coagulation-active substance. Int J Oral Surg 1976;5:3-7.
68. Sonis L, Musselman RJ. Oral bleeding in classic hemophilia. Oral Surg Oral Med Oral Pathol 1982;53:363-366.
69. Cosgriff SW. Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann Int Med 1953;38:278.
70. Tulloch J, Wright IS. Long term anticoagulant therapy: further experiences. Circulation 1954;8:523.
71. Roller L, Thomson JM. Evidence for rebound hypercoagulability. Lancet 1964;2:62.
72. Marshall J. Rebound phenomena after anticoagulant therapy in cerebrovascular disease. Circulation 1963;28:329.
73. Harenberg J, Haas R, Zimmerman R. Plasma hypercoagulability after termination of oral anticoagulants. Thromb Res 1983;29:627-633.
74. Roser SM, Rosenbloom B. Continued anticoagulation in oral surgery procedures. Oral Surg Oral Med Oral Pathol 1975;40:448-457.